ClinVar Miner

Submissions for variant NM_004168.4(SDHA):c.454G>T (p.Glu152Ter)

dbSNP: rs778737664
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001383931 SCV001583260 pathogenic Mitochondrial complex II deficiency, nuclear type 1; Paragangliomas 5 2023-11-19 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Glu152*) in the SDHA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SDHA are known to be pathogenic (PMID: 22974104, 24781757). This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with SDHA-related conditions. ClinVar contains an entry for this variant (Variation ID: 1071454). For these reasons, this variant has been classified as Pathogenic.
Ambry Genetics RCV002329405 SCV002634258 pathogenic Hereditary cancer-predisposing syndrome 2021-04-13 criteria provided, single submitter clinical testing The p.E152* pathogenic mutation (also known as c.454G>T), located in coding exon 4 of the SDHA gene, results from a G to T substitution at nucleotide position 454. This changes the amino acid from a glutamic acid to a stop codon within coding exon 4. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.